The Social Security Fund (CSS) announced it will invest $91,979,892.00 for the supply, storage, transportation, and delivery of 348 chemical synthesis medications over a 15-month period. This procedure ensures a timely supply of medications and guarantees that insured individuals receive their treatments without interruptions. The event was attended by 57 companies, demonstrating, according to the institution, a transparent, open, and clear procedure that promotes competition. The event was public and broadcast live on the CSS's YouTube channel, through which the items participating in this tender can be verified, which in turn guarantees the transparency of the act. According to the institution, this is the Unique Price Tender No. 01-2026, aimed at ensuring a continuous supply nationwide. "The Unique Price model allows for setting homogeneous prices for all CSS executive units nationwide and thus acquiring a larger quantity of medications at a better cost while maintaining quality," highlighted the institution. The included medications cover treatments for common and chronic diseases such as hypertension, type 2 diabetes, dyslipidemia, asthma, depression, anxiety, infectious diseases, allergies, among others.
Panama's Social Security Fund Invests $92 Million in Medication Procurement
Panama's Social Security Fund (CSS) is investing nearly $92 million to supply the country with 348 different medications for 15 months. A new unified pricing system aims to increase efficiency and ensure uninterrupted treatment for patients with chronic conditions.
